T5646

Cinnamic acid (β-Phenylacrylic acid) has potential use in cancer intervention,The concentration causing a 50% reduction of cell proliferation (IC50) ranged from 1 to 4.5 mM in glioblastoma, melanoma, prostate and lung carcinoma cells.

Cinnamic acid-13C3 is the 13C labeled variant of cinnamic acid (T5646), which is potentially useful in cancer treatment. It has demonstrated IC50 values ranging from 1 to 4.5 mM against glioblastoma, melanoma, prostate, and lung cancer cells.

Cinnamic acid-D6 is the deuterated form of Cinnamic acid (T5646). It shows potential applications in cancer treatment, with IC50 values ranging from 1 to 4.5 mM for glioblastoma, melanoma, prostate cancer, and lung cancer cells.